AU2003263988A1 - Methods and compositions to treat conditions associated with neovascularization - Google Patents

Methods and compositions to treat conditions associated with neovascularization

Info

Publication number
AU2003263988A1
AU2003263988A1 AU2003263988A AU2003263988A AU2003263988A1 AU 2003263988 A1 AU2003263988 A1 AU 2003263988A1 AU 2003263988 A AU2003263988 A AU 2003263988A AU 2003263988 A AU2003263988 A AU 2003263988A AU 2003263988 A1 AU2003263988 A1 AU 2003263988A1
Authority
AU
Australia
Prior art keywords
neovascularization
compositions
methods
conditions associated
treat conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263988A
Other versions
AU2003263988A8 (en
Inventor
Dai Ren
Kin-Ping Wong
Ming-Chung Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wackvom Ltd
Original Assignee
Wackvom Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wackvom Ltd filed Critical Wackvom Ltd
Publication of AU2003263988A8 publication Critical patent/AU2003263988A8/en
Publication of AU2003263988A1 publication Critical patent/AU2003263988A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2003263988A 2002-08-05 2003-08-05 Methods and compositions to treat conditions associated with neovascularization Abandoned AU2003263988A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40113002P 2002-08-05 2002-08-05
US60/401,130 2002-08-05
PCT/US2003/024455 WO2004012677A2 (en) 2002-08-05 2003-08-05 Methods and compositions to treat conditions associated with neovascularization

Publications (2)

Publication Number Publication Date
AU2003263988A8 AU2003263988A8 (en) 2004-02-23
AU2003263988A1 true AU2003263988A1 (en) 2004-02-23

Family

ID=31495928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263988A Abandoned AU2003263988A1 (en) 2002-08-05 2003-08-05 Methods and compositions to treat conditions associated with neovascularization

Country Status (6)

Country Link
EP (1) EP1545493A4 (en)
JP (1) JP2006508047A (en)
CN (1) CN1723017A (en)
AU (1) AU2003263988A1 (en)
TW (1) TW200407119A (en)
WO (1) WO2004012677A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004308919B2 (en) * 2003-12-22 2009-11-12 Alcon, Inc. Agents for treatment of glaucomatous retinopathy and optic neuropathy
ATE511836T1 (en) * 2005-04-29 2011-06-15 Univ Johns Hopkins METHOD FOR SUPPRESSING SKIN CARCINOGENESIS INDUCED BY UV LIGHT
WO2007130353A2 (en) * 2006-05-01 2007-11-15 Johns Hopkins University Phase 2 inducers, ppar-alpha agonists and related signalling pathways protect cartilage against inflammation, apoptosis and stress
EP2205237A1 (en) * 2007-10-16 2010-07-14 Johns Hopkins University Methods for protecting the skin from radiation insults
GB0811992D0 (en) * 2008-07-01 2008-08-06 Mithen Richard Treatment
US9532970B2 (en) 2014-07-09 2017-01-03 Darlene E. McCord Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
GB2346325A (en) 1999-02-02 2000-08-09 Wassen Int Ltd Formulation comprising a brassica extract or sulforaphane and resveratrol
US6433011B1 (en) 2000-03-08 2002-08-13 American Health Foundation Method for inhibiting formation of aberrant crypt foci in the colon of a mammal

Also Published As

Publication number Publication date
EP1545493A4 (en) 2006-01-11
CN1723017A (en) 2006-01-18
EP1545493A2 (en) 2005-06-29
JP2006508047A (en) 2006-03-09
WO2004012677A3 (en) 2005-02-24
TW200407119A (en) 2004-05-16
AU2003263988A8 (en) 2004-02-23
WO2004012677A2 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2003243531A1 (en) Fermentation methods and compositions
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003271944A1 (en) Methods for making water treatment compositions and compositions thereof
AU2003267644A1 (en) Dental compositions and methods
AU2003299088A1 (en) Nocturnal muscle enhancing composition and method
EP1778219A4 (en) Ascophyllum compositions and methods
AU2002230888A1 (en) Methods and compositions to treat conditions associated with neovascularization
AU2003299441A1 (en) Nf-hev compositions and methods of use
EP1720563A4 (en) Methods and compositions for the treatment of inflammation
WO2006063031A3 (en) Allelic variants of human factor viii
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
AU2003296469A1 (en) Dental compositions including enzymes and methods
ZA200508655B (en) Compositions and methods relating to stop-1
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
AU2003263988A1 (en) Methods and compositions to treat conditions associated with neovascularization
EP1601348A4 (en) Compositions and methods with enhanced therapeutic activity
AU2003275433A1 (en) Compositions and methods for treating pain
GB0327050D0 (en) Therapeutic methods compositions and uses
AU2003257965A1 (en) Phosphonamide and phosphonamide blend compositions and method to treat water
AU2003903363A0 (en) Methods and compositions for treating disorders of the extracellular matrix
AU2003276889A1 (en) Methods and compositions for drains and delivery lines
GB0418762D0 (en) Methods and compositions to treat glaucoma
GB0305699D0 (en) Therapeutic compositions and methods
AU2003220601A1 (en) Synergistic l-methadone compositions and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase